Feto-maternal correlation of PTX3, sFlt-1 and PlGF in physiological and pre-eclamptic pregnancies

References

• Diagnosis and management of preeclampsia. American College of Obstetricians and Gynecologists. Washington: Practice Bulletin #33 ACOG; 2002
   Google Scholar
• Sibai MB. Hypertension in pregnancy. Obstet Gynecol Clin North Am 1992;19:615–32
   PubMed Web of Science ®Google Scholar
• Berg CJ, MacKay AP, Qin C, Allaghan WM. Overview of maternal morbidity during hospitalization for labor and delivery in the united states: 1993–1997 and 2001–2005. Obstet Gynecol 2009;113:1075–81
   PubMed Web of Science ®Google Scholar
• Shamshirsaz AA, Paidas M, Krikun G. Preeclampsia, hypoxia, thrombosis, and inflammation. J Pregnancy 2012;2012:374047. doi: 10.1155/2012/374047
   PubMedGoogle Scholar
• Dulei L. The global impact of preeclampsia and eclampsia. Semin Perinatol 2009;33:130–7
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499–506
   PubMed Web of Science ®Google Scholar
• Redman CWG, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–4
   PubMed Web of Science ®Google Scholar
• Ramma W, Ahamed A. Is inflammation the cause of preeclampsia? Biochem Soc Trans 2011;39:1619–27
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006;11:309–16
   PubMed Web of Science ®Google Scholar
• Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005;23:337–66
   PubMed Web of Science ®Google Scholar
• Larsson A, Palm M, Helmersson J, Axelsson O. Pentraxin 3 values during normal pregnancy. Inflammation 2011;34:448–51
   PubMed Web of Science ®Google Scholar
• Rovere Querini P, Antonacci S, Dell'Antonio G, et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol 2006;108:148–55
   PubMed Web of Science ®Google Scholar
• Castiglioni MT, Scavini M, Cavallin R, et al. Elevation of plasma levels of pentraxin 3 precedes preeclampsia in pregnant patients with type 1 diabetes. Autoimmunity 2009;42:296–8
   PubMed Web of Science ®Google Scholar
• Cetin I, Cozzi V, Papageorghiou AT, et al. First trimester PTX3 levels in woman who subsequently develop preeclampsia and fetal growth restriction. Acta Obstet Gynecol Scand 2009;88:846–9
   PubMed Web of Science ®Google Scholar
• Cetin I, Cozzi V, Pasqualin F, et al. Elevated maternal level of long pentraxin 3 in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2006;194:1347–53
   PubMed Web of Science ®Google Scholar
• Zhou P, Luo X, Qi HB, et al. The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum. Inflamm Res 2012;61:1005–12
   PubMed Web of Science ®Google Scholar
• Akolekar R, Casagrandi D, Livanos P, et al. Maternal plasma pentraxin 3 at 11 to 13 week of gestation in hypertensive disorder of pregnancy. Prenatal Diagnosis 2009;29:934–8
   PubMed Web of Science ®Google Scholar
• Rangeen RH, Eriksson MJ, Berg E, et al. Impaired endothelial function an elevated levels of pentraxin 3 in early onset preeclampsia. Acta Obstet Gynecol Scand 2012;91:50–6
   PubMed Web of Science ®Google Scholar
• Cozzi V, Garlanda C, Nebuloni M, et al. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Placenta 2012;33:1039–44
   PubMed Web of Science ®Google Scholar
• Hamad RR, Eriksson M, Berg E, et al. Impaired endothelial function and elevated levels of pentraxin 3 in early onset preeclampsia. Acta Obstet Gynecol Scand 2012;91:50–6
   PubMed Web of Science ®Google Scholar
• Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353–64
   PubMed Web of Science ®Google Scholar
• Shore VH, Wang TH, Wang CL, et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997;18:657–65
   PubMed Web of Science ®Google Scholar
• Makrydimas G, Sotiriadis A, Savvidou MD, et al. Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy. Prenatal Diagn 2008;28:175–9
   PubMed Web of Science ®Google Scholar
• Palm M, Basu S, Larsson A, et al. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy. Acta Obstet Gynecol Scand 2011;90:1244–51
   PubMed Web of Science ®Google Scholar
• Grill S, Rusterholz C, Zanetti Dallebbach R, et al. Potential markers of preeclampsia – a review. Reprod Biol Endocrinol 2009;7:70. doi: 10.1186/1477-7827-7-70
   PubMed Web of Science ®Google Scholar
• Cetin I, Huppertz B, Burton G, et al. Pregenesys preeclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 2010;32:1–13
   PubMed Web of Science ®Google Scholar
• Furuya M, Kurasawa K, Nagahama K, et al. Disturbed balance of angiogenic and antiangiogenic signalings in preeclampsia. J Pregnancy 2011;2011:123717. doi: 10.1155/2011/123717
   PubMedGoogle Scholar
• Kleinrouweler CE, Wiegerinck MMJ, Ris-Stalpers C, et al. for EBM CONNECT Collaboration. Accuracy of circulating placental growth factor, soluble fms like tyrosine kinase 1 and soluble endoglin in the prediction of preeclampsia: a systematic review and meta-analysis. BJOG 2012;119:778–87
   PubMed Web of Science ®Google Scholar
• Ghosh SK, Raheja S, Tuli A, et al. Serum PLGF as a potential biomarker for predicting the onset of preeclampsia. Arch Gynecol Obstet 2011;285:417–22
   PubMed Web of Science ®Google Scholar
• Bujold E, Romero R, Chaiworapongsa T, et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med 2005;18:9–16
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–58
   PubMed Web of Science ®Google Scholar
• Nicolini U, Todros T, Ferrazzi E, et al. Transverse fetal growth curves. A multicenter study. Min Gin 1986;38:873–87
   PubMedGoogle Scholar
• Bertino E, Spada E, Occhi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. JPGN 2010;51:353–61
   Google Scholar
• Staff AC, Braekke K, Harsem NK, et al. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005;122:33–9
   PubMed Web of Science ®Google Scholar
• Wallener W, Sengenberger R, Strick R, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) 2007;112:51–7
   PubMed Web of Science ®Google Scholar
• Bottazzi B, Vouret-Craviari V, Bastone A, et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 1997;272:32817–23
   PubMed Web of Science ®Google Scholar
• Rajakumar A, Powers RW, Hubel CA, et al. Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. Placenta 2009;30:25–34
   PubMed Web of Science ®Google Scholar
• The biochemistry and role of placental growth factor (PlGF). Available at: www.perkinelmer.com 1244-9917-01 [last accessed June 2009]
   Google Scholar
• Ferreira I, Peeters LL, Stehouwer CD. Pre-eclampsia and increased blood pressure in the offspring: meta-analysis and critical review of the evidence. J Hypertens 2009;27:1955–9
   PubMed Web of Science ®Google Scholar
• Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011;25:391–403
   PubMed Web of Science ®Google Scholar